Abstract
The purpose of this study is to compare the efficacy of EPX-100 against placebo as adjunctive therapy in patients with Dravet Syndrome.
The purpose of this study is to compare the efficacy of EPX-100 against placebo as adjunctive therapy in patients with Dravet Syndrome.
Stanley Manne Children's Research Institute
Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center
303 East Superior Street
Chicago, IL 60611
